Michael Petusky
Stock Analyst at Barrington Research
(2.26)
# 2,738
Out of 5,147 analysts
230
Total ratings
40.29%
Success rate
-1.98%
Average return
Main Sectors:
Stocks Rated by Michael Petusky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANIK Anika Therapeutics | Maintains: Outperform | $16 → $17 | $14.36 | +18.38% | 22 | Feb 27, 2026 | |
| LMAT LeMaitre Vascular | Maintains: Outperform | $95 → $105 | $108.18 | -2.94% | 15 | Feb 26, 2026 | |
| OFIX Orthofix Medical | Maintains: Outperform | $18 → $17 | $13.53 | +25.65% | 6 | Feb 25, 2026 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $106 → $109 | $77.18 | +41.23% | 26 | Feb 25, 2026 | |
| HSIC Henry Schein | Maintains: Outperform | $79 → $97 | $82.39 | +17.73% | 19 | Feb 25, 2026 | |
| USPH U.S. Physical Therapy | Maintains: Outperform | $103 | $82.96 | +24.16% | 27 | Feb 20, 2026 | |
| BVS Bioventus | Initiates: Outperform | $13 | $8.78 | +48.06% | 1 | Feb 9, 2026 | |
| HAE Haemonetics | Maintains: Outperform | $93 → $94 | $63.32 | +48.45% | 36 | Feb 6, 2026 | |
| OPCH Option Care Health | Maintains: Outperform | $38 → $42 | $32.46 | +29.39% | 19 | Jan 16, 2026 | |
| VRME VerifyMe | Maintains: Outperform | $1 → $1.5 | $0.95 | +57.40% | 11 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $14 | $14.68 | -4.63% | 27 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $2.25 | $1.20 | +87.50% | 15 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $7.20 | - | 6 | Aug 28, 2024 |
Anika Therapeutics
Feb 27, 2026
Maintains: Outperform
Price Target: $16 → $17
Current: $14.36
Upside: +18.38%
LeMaitre Vascular
Feb 26, 2026
Maintains: Outperform
Price Target: $95 → $105
Current: $108.18
Upside: -2.94%
Orthofix Medical
Feb 25, 2026
Maintains: Outperform
Price Target: $18 → $17
Current: $13.53
Upside: +25.65%
Merit Medical Systems
Feb 25, 2026
Maintains: Outperform
Price Target: $106 → $109
Current: $77.18
Upside: +41.23%
Henry Schein
Feb 25, 2026
Maintains: Outperform
Price Target: $79 → $97
Current: $82.39
Upside: +17.73%
U.S. Physical Therapy
Feb 20, 2026
Maintains: Outperform
Price Target: $103
Current: $82.96
Upside: +24.16%
Bioventus
Feb 9, 2026
Initiates: Outperform
Price Target: $13
Current: $8.78
Upside: +48.06%
Haemonetics
Feb 6, 2026
Maintains: Outperform
Price Target: $93 → $94
Current: $63.32
Upside: +48.45%
Option Care Health
Jan 16, 2026
Maintains: Outperform
Price Target: $38 → $42
Current: $32.46
Upside: +29.39%
VerifyMe
Jan 6, 2026
Maintains: Outperform
Price Target: $1 → $1.5
Current: $0.95
Upside: +57.40%
Jan 5, 2026
Maintains: Outperform
Price Target: $14
Current: $14.68
Upside: -4.63%
Oct 30, 2025
Maintains: Outperform
Price Target: $2.25
Current: $1.20
Upside: +87.50%
Aug 28, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $7.20
Upside: -